Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer
Fatemeh Khojasteh‐Leylakoohi(Mashhad University of Medical Sciences), Amir Avan(Queensland University of Technology), Alireza Asadnia(Mashhad University of Medical Sciences), Mina Maftooh(Mashhad University of Medical Sciences), Gordon A. Ferns(Brighton and Sussex Medical School), Elham Nazari(Mashhad University of Medical Sciences), Elisa Giovannetti(University of Pisa), Reza Mohit(Bushehr University of Medical Sciences), Jyotsna Batra(Translational Research Institute), Nima Khalili‐Tanha(Mashhad University of Medical Sciences), Ghazaleh Khalili‐Tanha(Mashhad University of Medical Sciences), Mohammadreza Nassiri(Ferdowsi University of Mashhad), Zahra Yousefli(Mashhad University of Medical Sciences), Ghazaleh Pourali(Mashhad University of Medical Sciences), HamidReza Naderi(Mashhad University of Medical Sciences), Seyed Mahdi Hassanian(Mashhad University of Medical Sciences), Majid Ghayour‐Mobarhan(Mashhad University of Medical Sciences), Majid Khazaei(Mashhad University of Medical Sciences), Soodabeh Shahidsales(Mashhad University of Medical Sciences), Alfred K. Lam(Griffith University)
Cited by 17
Related Papers
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
|Nature Genetics|2018|1k
Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
|International Journal of Oral Science|2020|259
Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
|Drug Resistance Updates|2019|198
Entrectinib: a potent new TRK, ROS1, and ALK inhibitor
|Expert Opinion on Investigational Drugs|2015|153
Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
|npj Precision Oncology|2023|146